CAEHR (CArdiovascular Diseases-Enhancing Healthcare through cross-Sectoral Routine data integration)


CArdiovascular Diseases-Enhancing Healthcare through cross-Sectoral Routine data integration

Duration of the project: August 2021 - July 2025


Cardiovascular diseases (CVD) are still the leading cause of death in Germany. The strict separation between inpatient and outpatient care in Germany has been one of the major obstacles for the availability of patients’ health information for strategic therapy planning and emergency care.

In CAEHR we aim to extend data integration and availability to the full multi-institutional and multi-professional patient journey. This is realized in close collaboration with patients, health professionals, researchers, IT companies and health care insurance companies.

The consortium combines strong intersectoral, long lasting regional partnerships in patient care in three complementary use cases. Theses use cases are each implemented in one of the participating regional centers (Würzburg, Göttingen/Hannover & Berlin) in close collaboration with the roll-out partners of one of the remaining centers, see Figure.

In close cooperation with Vivantes, Charité is leading the use case C - Outpatient Care.

Read more Charité press release

Read more Federal Ministry of Education and Research press release 



Figure: Consortium/regions and use cases


BMBF_gefördert vom_en

Latest News

SBHD 2024

Our colleagues at Vanderbilt University organise the 16th INTERNATIONAL CONFERENCE ON SYSTEMS BIOLOGY OF HUMAN DISEASE – SBHD 2024 this year from June 10-12. Don’t miss the opportunity to participate

Top 100 Köpfe der Wissenschaft 2023

Am 11.10.2023 wurde Prof. Roland Eils im Tagesspiegel als einer der 100 wichtigsten Köpfe der Hauptstadt-Wissenschaft gewürdigt. So schreibt der Tagesspiegel: "Um Big Data dreht sich alles in der

Young BIH scientists attend 72nd Lindau Nobel Laureate Meeting

The Lindau Nobel Laureate Meetings are annual conferences where some of the brightest minds in science converge to exchange knowledge, foster collaboration, and inspire the next generation of

Roland Eils wird als Highly Cited Researcher international gelistet.

Roland Eils gehört zu den weltweit am häufigsten zitierten Forschenden des Jahres 2022, wie aus der Liste der „Highly Cited Researchers“ hervorgeht, die das Unternehmen Clarivate heute veröffentlicht